Genomic Biomarker Market 2025 Opportunity, Challenge, Drivers, and Global Growth by 2031 | Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., QIAGEN

Genomic Biomarker Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database.

The Genomic Biomarker Market focuses on molecular indicators derived from DNA, RNA, or proteins, used to detect disease, predict progression, and guide targeted therapies. These biomarkers play a critical role in personalized medicine, oncology, and drug development. Market growth is fueled by rising demand for precision diagnostics, increasing investments in genomics research, and advancements in sequencing technologies. Pharmaceutical companies, research laboratories, and clinical diagnostic centers are key end-users. Adoption of genomic biomarkers enables early disease detection, tailored treatments, and improved patient outcomes.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Genomic Biomarker Market Landscape:- https://datamintelligence.com/download-sample/genomic-biomarker-market?rk

☛ Genomic Biomarker Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In September 2025, Quest Diagnostics launched an advanced pharmacogenomics (PGx) test in collaboration with Coriell Life Sciences. This service aims to assist clinicians in optimizing drug prescriptions by understanding individual genetic responses, thereby enhancing personalized medicine.

✅ In July 2025, GeneDx announced the acquisition of AI-focused genomic firm Fabric Genomics for up to $51 million. This acquisition is set to enhance GeneDx's capabilities in integrating AI with genomic interpretation, aiming to provide faster and scalable insights into genetic diseases.

✅ In May 2025, Illumina received regulatory approval in Japan for its TruSightTM Oncology Comprehensive test. This genomic profiling tool is expected to expand access to precision oncology options for patients in Japan.

Japan: Recent Industry Developments

✅ In September 2025, Otsuka Pharmaceutical's Diagnostic Division inaugurated a new laboratory in Tokyo. The facility focuses on biomarker and digital biomarker research to strengthen connections with users and enhance diagnostic capabilities.

✅ In June 2025, SoftBank Group launched a joint venture with Tempus AI to analyze personal medical data using AI for treatment recommendations. This collaboration aims to extend Tempus's genomic testing and AI-based services to Japan, marking a significant step in personalized healthcare.

✅ In April 2025, GeneDx announced a deal to acquire AI-focused genomic firm Fabric Genomics for up to $51 million. This acquisition is intended to enhance the integration of AI and human expertise in genomic interpretation, enabling faster, scalable insights.

☛ Genomic Biomarker Market Trends:

The genomic biomarker market is experiencing growth due to the increasing demand for precision medicine and personalized therapies across oncology, rare diseases, and chronic conditions. Advances in sequencing technologies and high-throughput genomics are enabling better biomarker discovery and patient stratification.

Key trends include integration with AI and machine learning for biomarker analysis, development of multi-omics approaches, and expansion of companion diagnostics to support targeted therapies. Regulatory support for biomarker-driven treatment decisions is also fueling adoption.

☛ Genomic Biomarker Market Competitve Landscape:

Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., QIAGEN, Eurofins Scientific, Exact Sciences, Sema4, Creative Diagnostics, Centogene N.V., Quanterix.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/genomic-biomarker-market

☛ Segment Covered in the Genomic Biomarker Market:

By Type: Predictive Biomarkers, Prognostic Biomarkers

By Validation: Analytical Validation, Clinical Validation, Clinical Utility, Others

By Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Others

By End-User: Hospitals, Diagnostic Centers, Research Laboratories, Others

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Genomic Biomarker Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=genomic-biomarker-market

☛ Regional Analysis for Genomic Biomarker Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Genomic Biomarker Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Genomic Biomarker Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Genomic Biomarker Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.